Finbar O’Callaghan is Professor of Paediatric Neuroscience at the UCL GOS Institute of Child Health, University College London and (Hon) Consultant Paediatric Neurologist at Great Ormond Street Hospital. He was President of the British Paediatric Neurology Association (BPNA) (2017-2020) and Secretary of the European Paediatric Neurology Association (EPNS) (2013-2017)

Finbar graduated from Oxford with a MA (Hons) in Modern History in 1983 before going on to study medicine at Bristol Medical School, graduating in 1990. He trained in paediatrics and paediatric neurology in Bristol, Bath, Birmingham, Toronto and Southampton. He trained in clinical epidemiology at the London School of Hygiene and Tropical Medicine and the MRC Environmental Epidemiology Unit in Southampton. He was awarded his MSc in Epidemiology in 1997 and PhD in 2002. Subsequently, he was Senior Clinical Research Fellow at the National Perinatal Epidemiology Unit, University of Oxford. Finbar was appointed Consultant Paediatric Neurologist in Bristol in 2003 before moving to Great Ormond Street Hospital in London in 2013.

Finbar’s research has been in the area of neuroepidemiology and clinical trials, specifically ininfantile epilepsies, tuberous sclerosis complex and stroke. He was Chief Investigator of the investigator-led International Collaborative Infantile Spasm Study (ICISS), the Metformin Tuberous Sclerosis Study (MiTS) and the Study of Outcome of Childhood Stroke (SOCS). He has also been UK Chief Investigator of the industry studies of Everolimus in Tuberous Sclerosis (EXIST Trials 1&3) and Epidiolex in Tuberous Sclerosis (GWPCARE6).